EP1165500A1 — Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
Assigned to Bristol Myers Squibb Pharma Co · Expires 2002-01-02 · 24y expired
What this patent protects
The present application describes novel amides and derivatives thereof of formula (I) or pharmaceutically acceptable salt forms thereof, wherein these compounds are useful as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase.
USPTO Abstract
The present application describes novel amides and derivatives thereof of formula (I) or pharmaceutically acceptable salt forms thereof, wherein these compounds are useful as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.